RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5578
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1454800; Gene model (P.falciparum): PF3D7_1241400; Gene product: RNA-binding protein, putative (fd1 (female-defective 1) protein)
Transgene
Transgene not Plasmodium: Cas9, N-terminal flag-tagged
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_1454800; Gene product: RNA-binding protein, putative (fd1 (female-defective 1) protein)
Transgene
Transgene not Plasmodium: Blue Fluorescence Protein (BFP)
Promoter: Gene model: PBANKA_0711900; Gene model (P.falciparum): PF3D7_0818900; Gene product: heat shock protein 70 (HSP70)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_1454800; Gene product: RNA-binding protein, putative (fd1 (female-defective 1) protein)
Phenotype Gametocyte/Gamete; Fertilization and ookinete; Oocyst;
Last modified: 12 November 2024, 18:50
  *RMgm-5578
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene, Introduction of a transgene
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA cl15cy1
Other information parent lineA reference wild type clone from the ANKA strain of P. berghei (PubMed: PMID: 17406255).
The mutant parasite was generated by
Name PI/ResearcherBalakrishnan A, Billker O
Name Group/DepartmentThe Laboratory for Molecular Infection Medicine Sweden
Name InstituteUmeå University
CityUmeå
CountrySweden
Name of the mutant parasite
RMgm numberRMgm-5578
Principal namefd1-cas9-bfp
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteInfertile females, fertile males.
Fertilization and ookineteInfertile females, fertile males.
Complete loss in the ability to form oocysts in mosquitoes
OocystComplete loss in the ability to form oocysts in mosquitoes
SporozoiteNot tested
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
In the female-defective mutant the female specific gene fd1 is disrupted (see also RMgm-5069. In addition, a CAS9 (N-terminal flag-tagged) and blue fluorescence reporter protein (bfp) expression cassette (under control of the constitutive hsp promoter) has been introduced into the disrupted fd1 locus. This mutant produces fertile male gametes but infertile female gametes.

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2024.06.02.597011

Protein (function)
FD1 (female-defective mutant ): see RMgm-5069

Phenotype

Infertile females, fertile males.
Complete loss in the ability to form oocysts in mosquitoes

Additional information
From the paper:

Abstract:
In this study, we developed a scalable genetic system that uses barcoded gene targeting vectors equipped with a CRISPR-mediated homing mechanism to generate homozygous loss-of-function mutants to reveal gene functions in the functionally diploid life cycle stages. In this system, a knockout vector additionally expressing a gRNA for its target is integrated into one of the parental alleles and directs Cas9 to the intact allele after fertilisation, leading to its disruption. We find that this homing strategy is 90% effective in the oocyst, resulting in the generation of homozygous genotypes.

In the homing screen (using crosses between gametocytes of two lines making only male or only female gametocytes (fd1; RMgm-5578) or male development 4 (md4; RMgm-5579)) it was found that two of three oocyst-expressed genes of unknown function, PBANKA_0916000 and PBANKA_1006400 showed a marked homing effect warranting further investigation. How mutants behave in the homing screen may be confounded by factors other than gene function, such as the efficiency of gRNAs, how much transcript or protein a zygote inherits from the female parent and how fast these turn over. To validate the result of the pilot screen we studied PBANKA_0916000 (RMgm-5580), a poorly understood gene with a new phenotype, which we find encodes a chloroquine resistance transporter like (CRTL) protein.

Single sex P. berghei lines expressing Cas9-BFP are fertile

Sex in haploid malaria parasites is not chromosomally determined, and parasite clones produce both male and female gametocytes. We reasoned that if we could genetically modify lines to produce gametes of only one or the other sex, these could be engineered further, such that in a genetic cross each sex would separately deliver either a Cas9 endonuclease or a guide RNA to the zygote and cause a double strand break in a target gene. Since Plasmodium parasites lack canonical non-homologous end joining, repair of double strand breaks is always homology driven. We therefore further reasoned that a disrupted target allele not recognized by the guide and carried by one of the parental lines would serve as repair template, leading to the disruption being copied from one parental genome to the other, generating a homozygous knock-out (KO).
To test this concept, we first created lines making only male or only female gametocytes by disrupting female development 1 (fd1; RMgm-5578) or male development 4 (md4; RMgm-5579), respectively. Clonal md4-cas9-bfp (female-only) parasites produced female gametes and did not produce male gametes and gave rise to ookinetes only when co-cultured with the fd1-cas9-bfp (male-only), which did release male gametes, as expected.  Also as expected, these single-sex lines produced no oocysts when transmitted individually, but oocyst formation was restored when mosquitoes were fed on mice co-infected with both lines.

Cas9-mediated genome editing after fertilisation is efficient.

To quantitate the efficiency of Cas9-mediated genome editing after fertilisation at the level of individual oocysts, we designed a colour swapping experiment. This involved constructing complementary single-sex lines in which the endogenous MyoA protein was either fused to mCherry or to GFP. MyoA is abundantly expressed during sporogony and tolerates c-terminal tagging12. We hypothesised that crossing single-sex lines expressing MyoAmCherry and MyoA-GFP, respectively, should make yellow oocysts. However, if the latter locus additionally expressed one or more gRNAs targeting Cas9 specifically to the mCherry locus , homology-mediated repair of a double-strand break would use the complementary GFP-containing allele as repair template, turning oocysts green.
Consistent with this concept, directional crosses between red and green parents produced yellow oocysts, unless either the female or the male gamete provided gRNAs targeting the mCherry locus (all crosses also delivered Cas9 to the zygote). Since md4 and fd1 mutants do not undergo selfing, we were surprised to see 1-3% of oocysts in these crosses express only one parental allele, indicating that some zygotes may obtain an incomplete genome from a parent or that occasionally not all four products of meiosis survive or replicate in the oocyst. Our data suggest homing happens with 97% efficiency when the gRNAs are expressed from the female gamete, but this is reduced to 89% if the male carries the guides. This colour swapping experiment demonstrates that we have developed a CRISPR method where the phenotype of the oocyst is dominated by only one parental allele, in this case myoa-gfp, irrespective of the route of inheritance.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1454800
Gene Model P. falciparum ortholog PF3D7_1241400
Gene productRNA-binding protein, putative
Gene product: Alternative namefd1 (female-defective 1) protein
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modificationFluorescence and drug resistance marker-free single-sex lines were generated by disrupting PBANKA_1454800 (fd1) or PBANKA_0102400 (md4), respectively6 using a CRISPR-RGR strategy (ribozyme guide ribozyme) with two sgRNAs to target the gene of interest (see also RMgm-4632) in the P. berghei clone cl15cy1. To construct a plasmid to express a CRISPR-Cas9 transgene, we modified the existing CRISPR-RGR strategy with two single guide RNAs (sgRNAs) to target the gene of interest. The sgRNAs were designed using Benchling, and the sgRNA cassette (containing the gRNA along with RGR) was synthesised (Azenta Life Sciences). Subsequently, the sgRNA cassette was cloned into the cas9 plasmid (MH_046) which carries a hdhfr selection cassette to generate PL_HC_014 (gRNA plasmid targeting md4) and PL_HC015 (gRNA plasmid targeting fd1). DNA fragments encoding an hsp70 promoter, Nterminal flag tagged cas9, bfp and dhfr 3’UTR were cloned into a plasmid and flanked with 500 bp sequences targeting either fd1 or md4 locus.

To generate the repair template, hsp70 promoter, cas9, bfp and Pbdhfr 3’UTR gene sequences were amplified from plasmids Pb_MH21 and R6K-GW-BFP (PL_HC_001) respectively using Advantage 2 Polymerase Mix (TaKaRa). Individual fragments were assembled by stitch PCR, digested with Kpn1 and Sac11, and ligated into an intermediated vector pMisc 017) to generate PL_HC013. The cas9-bfp fragment was sub-cloned into two pre-synthesized plasmids (Azenta Life Science) containing 500 bp sequences upstream and downstream of either fd1 or md4 gene locus to generate plasmid carrying repair template PL_HC_018 and PL_HC_017 respectively.

To generate transgenic single-sex lines expressing Cas9, P. berghei schizonts were co-transfected with 1 μg of the Cas9-sgRNA vector and linearized cas9bfp repair template targeting either the md4 or fd1 gene locus.

Transfected parasites were promptly injected intravenously into BALB/c mice and were subjected to selection with 0.07 mg/mL of pyrimethamine in drinking water starting from day one post-infection. Pyrimethamine selection was terminated on Day 5, and mice were administered 5-fluorocytosine (1 mg/mL, Sigma) via drinking water to eliminate the CRISPR plasmid carrying the dhfr/yfcu selection cassette (negative selection). Insertion of cas9 bfp in the md4 and fd1 gene loci was confirmed by PCR. Cas9-BFP expression in the nucleus was visualised by live imaging of infected cells.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameCas9, N-terminal flag-tagged
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modificationFluorescence and drug resistance marker-free single-sex lines were generated by disrupting PBANKA_1454800 (fd1) or PBANKA_010240o (md4), respectively6 using a CRISPR-RGR strategy (ribozyme guide ribozyme) with two sgRNAs to target the gene of interest (see also RMgm-4632) in the P. berghei clone cl15cy1. To construct a plasmid to express a CRISPR-Cas9 transgene, we modified the existing CRISPR-RGR strategy with two single guide RNAs (sgRNAs) to target the gene of interest. The sgRNAs were designed using Benchling, and the sgRNA cassette (containing the gRNA along with RGR) was synthesised (Azenta Life Sciences). Subsequently, the sgRNA cassette was cloned into the cas9 plasmid (MH_046) which carries a hdhfr selection cassette to generate PL_HC_014 (gRNA plasmid targeting md4) and PL_HC015 (gRNA plasmid targeting fd1). DNA fragments encoding an hsp70 promoter, Nterminal flag tagged cas9, bfp and dhfr 3’UTR were cloned into a plasmid and flanked with 500 bp sequences targeting either fd1 or md4 locus.

To generate the repair template, hsp70 promoter, cas9, bfp and Pbdhfr 3’UTR gene sequences were amplified from plasmids Pb_MH21 and R6K-GW-BFP (PL_HC_001) respectively using Advantage 2 Polymerase Mix (TaKaRa). Individual fragments were assembled by stitch PCR, digested with Kpn1 and Sac11, and ligated into an intermediated vector pMisc 017) to generate PL_HC013. The cas9-bfp fragment was sub-cloned into two pre-synthesized plasmids (Azenta Life Science) containing 500 bp sequences upstream and downstream of either fd1 or md4 gene locus to generate plasmid carrying repair template PL_HC_018 and PL_HC_017 respectively.

To generate transgenic single-sex lines expressing Cas9, P. berghei schizonts were co-transfected with 1 μg of the Cas9-sgRNA vector and linearized cas9bfp repair template targeting either the md4 or fd1 gene locus.

Transfected parasites were promptly injected intravenously into BALB/c mice and were subjected to selection with 0.07 mg/mL of pyrimethamine in drinking water starting from day one post-infection. Pyrimethamine selection was terminated on Day 5, and mice were administered 5-fluorocytosine (1 mg/mL, Sigma) via drinking water to eliminate the CRISPR plasmid carrying the dhfr/yfcu selection cassette (negative selection). Insertion of cas9 bfp in the md4 and fd1 gene loci was confirmed by PCR. Cas9-BFP expression in the nucleus was visualised by live imaging of infected cells.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_1454800
Gene productRNA-binding protein, putative
Gene product: Alternative namefd1 (female-defective 1) protein
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameBlue Fluorescence Protein (BFP)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedure5-fluorocytosine (5-FC)
Additional remarks genetic modificationFluorescence and drug resistance marker-free single-sex lines were generated by disrupting PBANKA_1454800 (fd1) or PBANKA_010240o (md4), respectively6 using a CRISPR-RGR strategy (ribozyme guide ribozyme) with two sgRNAs to target the gene of interest (see also RMgm-4632) in the P. berghei clone cl15cy1. To construct a plasmid to express a CRISPR-Cas9 transgene, we modified the existing CRISPR-RGR strategy with two single guide RNAs (sgRNAs) to target the gene of interest. The sgRNAs were designed using Benchling, and the sgRNA cassette (containing the gRNA along with RGR) was synthesised (Azenta Life Sciences). Subsequently, the sgRNA cassette was cloned into the cas9 plasmid (MH_046) which carries a hdhfr selection cassette to generate PL_HC_014 (gRNA plasmid targeting md4) and PL_HC015 (gRNA plasmid targeting fd1). DNA fragments encoding an hsp70 promoter, Nterminal flag tagged cas9, bfp and dhfr 3’UTR were cloned into a plasmid and flanked with 500 bp sequences targeting either fd1 or md4 locus.

To generate the repair template, hsp70 promoter, cas9, bfp and Pbdhfr 3’UTR gene sequences were amplified from plasmids Pb_MH21 and R6K-GW-BFP (PL_HC_001) respectively using Advantage 2 Polymerase Mix (TaKaRa). Individual fragments were assembled by stitch PCR, digested with Kpn1 and Sac11, and ligated into an intermediated vector pMisc 017) to generate PL_HC013. The cas9-bfp fragment was sub-cloned into two pre-synthesized plasmids (Azenta Life Science) containing 500 bp sequences upstream and downstream of either fd1 or md4 gene locus to generate plasmid carrying repair template PL_HC_018 and PL_HC_017 respectively.

To generate transgenic single-sex lines expressing Cas9, P. berghei schizonts were co-transfected with 1 μg of the Cas9-sgRNA vector and linearized cas9bfp repair template targeting either the md4 or fd1 gene locus.

Transfected parasites were promptly injected intravenously into BALB/c mice and were subjected to selection with 0.07 mg/mL of pyrimethamine in drinking water starting from day one post-infection. Pyrimethamine selection was terminated on Day 5, and mice were administered 5-fluorocytosine (1 mg/mL, Sigma) via drinking water to eliminate the CRISPR plasmid carrying the dhfr/yfcu selection cassette (negative selection). Insertion of cas9 bfp in the md4 and fd1 gene loci was confirmed by PCR. Cas9-BFP expression in the nucleus was visualised by live imaging of infected cells.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_0711900
Gene Model P. falciparum ortholog PF3D7_0818900
Gene productheat shock protein 70
Gene product: Alternative nameHSP70
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_1454800
Gene productRNA-binding protein, putative
Gene product: Alternative namefd1 (female-defective 1) protein
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4